AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

651.433

+16.4832.60%

Number of Gainers:11

Number of Losers:10

Number of Flat:22

PE:- -

High:652.204

Open:632.825

Low:632.825

Close:634.950

Volume:47.54M

Turnover:129.24M

Market Cap:92.90B

Float Cap:89.72B

Loading ...

Proteomics International Laboratories - There were no Dividends Paid, Recommended or Declared During Current Financial Period

THOMSON REUTERS

Tissue Repair Posts FY Loss Attributable of A$5.4 Million

Tissue Repair Ltd - FY Revenues from Ordinary Activities A$3.2 Mln

THOMSON REUTERS

Tissue Repair - no Dividends Paid, Recommended or Declared During Current Financial Period

THOMSON REUTERS

Analysts Just Shaved Their Mesoblast Limited (ASX:MSB) Forecasts Dramatically

Simply Wall St.

Cann Group Ltd-Preliminary Final Report

THOMSON REUTERS

Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026

THOMSON REUTERS

Australia's Immutep Falls to Near 3-Week Low as 2026 Loss Widens

Orthocell Ltd - no Dividends Have Been Declared

THOMSON REUTERS

Orthocell Ltd - FY Revenue from Ordinary Activities A$11.4 Mln

THOMSON REUTERS

Immutep Says no Dividends Paid or Declared During Current FY

Cynata Therapeutics - no Dividends Declared for Fy2026

THOMSON REUTERS

Cynata Therapeutics - Fy2026 Loss from Ordinary Activities After Tax A$9.1 Mln

THOMSON REUTERS

Anteotech Ltd - FY Revenues from Ordinary Activities A$467,589

THOMSON REUTERS

Anteotech Ltd - Loss for Year Attributable A$4.9 Mln

THOMSON REUTERS

Immutep - FY Loss Attributable A$79.3 Mln

THOMSON REUTERS

Spotlight for Clinuvel Turning to Vitiligo Trial Readout

Monash IVF Group - Appoints Catherine West as Chair-Elect to Succeed Richard Davis as Chair

THOMSON REUTERS

Monash IVF Group Ltd-Mvf Board Succession and Renewal

THOMSON REUTERS

Monash IVF Group - Richard Henshaw to Retire on 28 October 2026; Neil Broekhuizen to Retire on 31 August 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK7508/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":651.433,"timestamp":1789365599822,"preClose":634.9499,"halted":0,"volume":47539051,"delay":0,"changeRate":0.02596,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":16.483093,"latestTime":"09-14 16:00:00 AEST","open":632.8247,"high":652.2035,"low":632.8247,"amount":129241804,"amplitude":0.03052,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789344000000,1789365600000]],"turnoverRate":0.001864,"increases":13,"decrements":12,"flats":18,"marketCap":92903929115.25,"floatMarketCap":89720799305.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":652.2035,"amplitude":0.03052,"preClose":634.9499,"low":632.8247,"latestPrice":651.433,"volume":47539051,"delay":0,"open":632.8247,"prevYearClose":644.3692,"prevWeekClose":634.95,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":661.74,"twentyDayClose":539.618,"sixtyDayClose":448.43,"secType":"PLATE","market":"AU","turnoverRate":0.001864,"marketCap":92903929115.25,"floatMarketCap":89720799305.375,"timestamp":1789365599822,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":11,"down":10,"flat":22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663027285","title":"Proteomics International Laboratories - There were no Dividends Paid, Recommended or Declared During Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663027285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663027285?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:40","pubTimestamp":1788158409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022015","title":"Tissue Repair Posts FY Loss Attributable of A$5.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663022015?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:13","pubTimestamp":1788156830,"startTime":"0","endTime":"0","summary":"BRIEF-Tissue Repair Posts FY Loss Attributable Of A$5.4 MillionAug 31 (Reuters)-Tissue Repair LtdTRP.AX:FY REVENUES FROM ORDINARY ACTIVITIES A$3.2 MILLIONFY LOSS ATTRIBUTABLE A$5.4 MILLIONNO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING CURRENT FINANCIAL PERIODFurther company coverage:TRP.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R049:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","TRP.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663220680","title":"Tissue Repair Ltd - FY Revenues from Ordinary Activities A$3.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663220680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663220680?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:12","pubTimestamp":1788156734,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R049:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRP.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663065022","title":"Tissue Repair - no Dividends Paid, Recommended or Declared During Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663065022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663065022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:12","pubTimestamp":1788156734,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R049:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","TRP.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663607448","title":"Analysts Just Shaved Their Mesoblast Limited (ASX:MSB) Forecasts Dramatically","url":"https://stock-news.laohu8.com/highlight/detail?id=2663607448","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663607448?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:37","pubTimestamp":1788151054,"startTime":"0","endTime":"0","summary":"One thing we could say about the analysts on Mesoblast Limited ( ASX:MSB ) - they aren't optimistic, having just made a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/analysts-just-shaved-their-mesoblast-limited-asxmsb-forecast","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/analysts-just-shaved-their-mesoblast-limited-asxmsb-forecast","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663021480","title":"Cann Group Ltd-Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2663021480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663021480?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAN.AU","BK7508","BK7502","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002145","title":"Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002145?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","BK7508","CAN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663021517","title":"Australia's Immutep Falls to Near 3-Week Low as 2026 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2663021517","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663021517?lang=en_us&edition=fundamental","pubTime":"2026-08-31 11:40","pubTimestamp":1788147609,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Immutep falls to near 3-week low as 2026 loss widens** Shares of ImmutepIMM.AXfell as much as 4% to A$0.048, marking their lowest level since August 12** Biotechnology firm'sannual losswidens by 29.1% to A$79.3 million  from A$61.4 million in 2025** Including day's moves, stock down 88.2% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S09S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663647029","title":"Orthocell Ltd - no Dividends Have Been Declared","url":"https://stock-news.laohu8.com/highlight/detail?id=2663647029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663647029?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:59","pubTimestamp":1788145149,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663029642","title":"Orthocell Ltd - FY Revenue from Ordinary Activities A$11.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663029642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663029642?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:59","pubTimestamp":1788145149,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663025976","title":"Immutep Says no Dividends Paid or Declared During Current FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2663025976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663025976?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:32","pubTimestamp":1788139963,"startTime":"0","endTime":"0","summary":"BRIEF-Immutep Says No Dividends Paid Or Declared During Current FYAug 31 (Reuters)-Immutep LtdIMM.AX:IMMUTEP LTD -  NO DIVIDENDS PAID OR DECLARED DURING CURRENT FYFurther company coverage:IMM.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P20Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663284430","title":"Cynata Therapeutics - no Dividends Declared for Fy2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663284430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663284430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:10","pubTimestamp":1788135014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R037:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CYP.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028432","title":"Cynata Therapeutics - Fy2026 Loss from Ordinary Activities After Tax A$9.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028432","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663028432?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:10","pubTimestamp":1788135014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","CYP.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663407270","title":"Anteotech Ltd - FY Revenues from Ordinary Activities A$467,589","url":"https://stock-news.laohu8.com/highlight/detail?id=2663407270","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663407270?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:31","pubTimestamp":1788132711,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nFWN44P210:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7036","BK7048","BK7508","ADO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663040720","title":"Anteotech Ltd - Loss for Year Attributable A$4.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663040720","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663040720?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:31","pubTimestamp":1788132711,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nFWN44P210:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADO.AU","BK7501","BK7508","BK7036","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663040149","title":"Immutep - FY Loss Attributable A$79.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663040149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663040149?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:14","pubTimestamp":1788131660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nPLXZ3JZPT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMM.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663040960","title":"Spotlight for Clinuvel Turning to Vitiligo Trial Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2663040960","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663040960?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:01","pubTimestamp":1788130860,"startTime":"0","endTime":"0","summary":"2300 GMT - The spotlight for Clinuvel Pharmaceuticals is increasingly turning to the readout of the CUV105 trial, says Jefferies. It is due by the end of December. Clinuvel is currently involved in a Phase 3 clinical trial of afamelanotide as a potential treatment for vitiligo, which affects some 0.75% of the U.S. population. Current treatment options are suboptimal, analyst David Stanton says. Vitiligo is a repigmentation disease with a large total addressable market of up to US$570 million in the first two years of entry to the market. \"Given Phase 2 trial results, we believe afamelanotide may eventually offer a more definitive, full-body solution than current standards of care in vitiligo,\" says Jefferies, which has a buy call on Clinuvel.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","CUV.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663470080","title":"Monash IVF Group - Appoints Catherine West as Chair-Elect to Succeed Richard Davis as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2663470080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663470080?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:30","pubTimestamp":1788129048,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE3YWG98:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7113","MVF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070047","title":"Monash IVF Group Ltd-Mvf Board Succession and Renewal","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070047","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663070047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:30","pubTimestamp":1788129048,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE3YWG98:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MVF.AU","BK7508","BK7113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004700","title":"Monash IVF Group - Richard Henshaw to Retire on 28 October 2026; Neil Broekhuizen to Retire on 31 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004700","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663004700?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:30","pubTimestamp":1788129048,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE3YWG98:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7113","MVF.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":106,"code":"91000000","status":"200"}]}}